Home | News | Directories | Calendar | Maps | Contact Us | Webmail
Perelman School of Medicine at the University of Pennsylvania Advanced Search

Tracey L. Evans, MD

Tracey L. Evans, MD

faculty photo
Associate Professor of Clinical Medicine
Department: Medicine

Contact information
16 Penn Tower
3400 Spruce Street
Philadelphia, PA 19104-4283
Office: 215-662-6681
Fax: 215-615-5888
BA (Biology and Philosophy)
University of Delaware, Summa Cum Laude, 1992.
University of Pennsylvania, 1996.
Permanent link
Perelman School of Medicine > Faculty > Search

Description of Research Expertise

Thoracic Malignancies
Lung Cancer

Description of Clinical Expertise

Thoracic Malignancies
Lung Cancer

Selected Publications

Martin J. Edelman, Ming T. Tan, Mary J. Fidler, Rachel E. Sanborn, Greg Otterson, Lecia V. Sequest, Tracey L. Evans, Bryan J. Schneider, Roger Keresztes, Johs S. Rogers, Jorge Antunez de Mayolo, Josephine Feliciano, Yang Yang, Michelle Medeiros, and Sara L. Zaknoen: Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Patients With Biomarker-Selected Non–Small-Cell Lung Cancer Journal of Clinical Oncology 33(2): 189-194, January 2015.

Preeti Sudheendra, Beth Gilbert, Dawna Gillespie, Mary Coniglio, Tracey L. Evans: Improving telephone management of patient clinical concerns. Poster presented at ASCO Quality Care Symposium, J Clin Oncol 32, 2014 (suppl 30; abstr 137) October 2014.

Bauml Joshua, Langer Corey J, Evans Tracey, Garland Sheila N, Desai Krupali, Mao Jun J: Does perceived control predict Complementary and Alternative Medicine (CAM) use among patients with lung cancer? A cross-sectional survey. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 22(9): 2465-72, Sep 2014.

Rangwala Reshma, Leone Robert, Chang Yunyoung C, Fecher Leslie A, Schuchter Lynn M, Kramer Amy, Tan Kay-See, Heitjan Daniel F, Rodgers Glenda, Gallagher Maryann, Piao Shengfu, Troxel Andrea B, Evans Tracey L, DeMichele Angela M, Nathanson Katherine L, O'Dwyer Peter J, Kaiser Jonathon, Pontiggia Laura, Davis Lisa E, Amaravadi Ravi K: Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma. Autophagy 10(8): 1369-79, Aug 2014.

Rangwala Reshma, Chang Yunyoung C, Hu Janice, Algazy Kenneth M, Evans Tracey L, Fecher Leslie A, Schuchter Lynn M, Torigian Drew A, Panosian Jeffrey T, Troxel Andrea B, Tan Kay-See, Heitjan Daniel F, DeMichele Angela M, Vaughn David J, Redlinger Maryann, Alavi Abass, Kaiser Jonathon, Pontiggia Laura, Davis Lisa E, O'Dwyer Peter J, Amaravadi Ravi K: Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma. Autophagy 10(8): 1391-402, Aug 2014.

Levy Benjamin, Spira Alexander, Becker Daniel, Evans Tracey, Schnadig Ian, Camidge D Ross, Bauman Julie E, Hausman Diana, Walker Luke, Nemunaitis John, Rudin Charles M, Halmos Balazs, Bowles Daniel W: A randomized, phase 2 trial of Docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic non-small-cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 9(7): 1031-5, Jul 2014.

Nathan A. Pennell, Joel W. Neal, Jamie E. Chaft, Christopher G. Azzoli, Pasi A. Janne, Ramaswamy Govindan, Tracey L. Evans, Daniel Botelho Costa, Rachel Pam Greenerger Rosovsky, Heather A. Wakelee, Rebecca Suk Heist, Alice Tsang Shaw, Jennifer S. Temel, Marc A. Shapiro, Alona Muzikansky, Michael Lanuti, Thomas James Lynch, Mark G. Kris, Lecia V. Sequist: SELECT: A multicenter phase II trial of adjuvant erlotinib in resected early-stage EGFR mutation-positive NSCLC. J Clin Oncol 32(5s): abstract 7514, May 2014.

T. Evans, B.C. Cho, K. Udud, J.R. Fischer, F.A. Shepherd, P. Martinez, R. Ramlau, K.N. Syrigos, M. Chadjaa, M. Wolf: Cabazitaxel (Cbz) vs topotecan (Tpt) in patients (pts) with small cell lung cancer (SCLC) with progressive disease during/after first-line (1L) treatment with platinum-based chemotherapy (ctx). Oral Presentation at the European Lung Cancer Conference, 2014 Published in Journal of Thoracic Oncology (2014) 9 (Supplement 9): S7-S52 March 2014.

Bauml Joshua, Mick Rosemarie, Zhang Yu, Watt Christopher D, Vachani Anil, Aggarwal Charu, Evans Tracey, Langer Corey: Determinants of survival in advanced non--small-cell lung cancer in the era of targeted therapies. Clinical lung cancer 14(5): 581-91, Sep 2013.

Bauml Joshua, Mick Rosemarie, Zhang Yu, Watt Christopher D, Vachani Anil, Aggarwal Charu, Evans Tracey, Langer Corey: Frequency of EGFR and KRAS mutations in patients with non small cell lung cancer by racial background: do disparities exist? Lung cancer (Amsterdam, Netherlands) 81(3): 347-53, Sep 2013.

back to top
Last updated: 02/19/2015
The Trustees of the University of Pennsylvania